<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[CV Therapeutics Inc. | Company News & Executive Profiles - CVTX | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/cv+therapeutics+inc..html?i=11]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for CV Therapeutics Inc.]]></description>
	<s:counts start="0" returned="8" found="8" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Why Is Gilead Buying CV Therapeutics?]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F125732-why-is-gilead-buying-cv-therapeutics%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Ockham Research submits:  &#8220;Another deal believe it or not in the drug industry has just come down. This time Gilead Sciences is buying CV Therapeutics, a $1.4 billion deal. We&#8217;ve seen so many acquisitions including Genentech-Roche which we talked about happening in recent days. $1.4 billion for CV Therapeutics...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 12 Mar 2009 01:34:25 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/ockham+research.html"><![CDATA[Ockham Research]]></category>
		<category domain="http://resources.bnet.com/topic/cv+therapeutics+inc..html"><![CDATA[CV Therapeutics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/gilead+sciences+inc..html"><![CDATA[Gilead Sciences Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CVTX</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GILD</category>
		<category domain="tickers">CVTX,GILD</category>
	</item>
	<item>
		<title><![CDATA[Astellas Announces Offer to Buy CV Therapeutics]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F123565-astellas-announces-offer-to-buy-cv-therapeutics%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Eben Tessari submits: Astellas (ALPMF.PK) announced that its indirect subsidiary, Sturgeon Acquisition, Inc., has commenced a cash tender offer for all outstanding shares of common stock of CV Therapeutics CVTX at a price of US$16.00 per share. The offer and withdrawal rights are scheduled to expire at 12:01 a.m., New...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 02 Mar 2009 07:54:53 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/eben+tessari.html"><![CDATA[Eben Tessari]]></category>
		<category domain="http://resources.bnet.com/topic/cv+therapeutics+inc..html"><![CDATA[CV Therapeutics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CVTX</category>
		<category domain="tickers">CVTX</category>
	</item>
	<item>
		<title><![CDATA[Will CV Therapeutics Get a Higher Price from Astellas?]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F116782-will-cv-therapeutics-get-a-higher-price-from-astellas%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Kirk Shinkle submits: Tokyo-based pharma company Astellas Pharma offered $1 billion in cash or $16 a share for CV Therapeutics CVTX, which makes small molecule cardiovascular drugs including angina treatment Ranexa. The deal is a 41 percent premium to CVTX's closing price, and shares promptly jumped today in expectation of...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 27 Jan 2009 10:46:34 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/kirk+shinkle.html"><![CDATA[Kirk Shinkle]]></category>
		<category domain="http://resources.bnet.com/topic/cv+therapeutics+inc..html"><![CDATA[CV Therapeutics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CVTX</category>
		<category domain="tickers">CVTX</category>
	</item>
	<item>
		<title><![CDATA[CV Therapeutics, Inc. Q3 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-250453.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator instructions Your first question is from the line of Jim Birchenough. Jim Birchenough &#8211; Barclays Capital  Hi, guys, congratulations on the label expansion. Louis Lange  Thank you. Jim Birchenough &#8211; Barclays Capital  So, just a few questions. Number one, just wondering how you're...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 19 Nov 2008 04:24:27 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[Patient]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/drug.html"><![CDATA[Drug]]></category>
		<category domain="http://resources.bnet.com/topic/cv+therapeutics+inc..html"><![CDATA[CV Therapeutics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/beta+blocker.html"><![CDATA[Beta Blocker]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[Patient]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/drug.html"><![CDATA[Drug]]></category>
		<category domain="http://resources.bnet.com/topic/cv+therapeutics+inc..html"><![CDATA[CV Therapeutics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/beta+blocker.html"><![CDATA[Beta Blocker]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CVTX</category>
		<category domain="tickers">CVTX</category>
	</item>
	<item>
		<title><![CDATA[CV Therapeutics, Inc. Q2 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-224916.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator  Operator Instruction. Your first question comes from the line of Jim Birchenough with Lehman Brothers. Jim Birchenough - Lehman Brothers. Guys, congratulations on the quarter. Louis Lange Thanks, Jim. Jim Birchenough - Lehman Brothers. So, just a question on the process with FDA right now around...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 31 Jul 2008 17:05:27 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/cv+therapeutics+inc..html"><![CDATA[CV Therapeutics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CVTX</category>
		<category domain="tickers">CVTX</category>
	</item>
	<item>
		<title><![CDATA[CV Therapeutics Inc. Q1 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-228076.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator Instructions. Your first question comes from the line of Bret Holley with Oppenheimer & Co. Bret Holley - Oppenheimer & Co Congratulations on the approval. Louis Lange Thanks, Bret. Bret Holley - Oppenheimer & Co Hey, I just got a question about the relative timing of...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Fri, 25 Apr 2008 10:06:09 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/cv+therapeutics+inc..html"><![CDATA[CV Therapeutics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CVTX</category>
		<category domain="tickers">CVTX</category>
	</item>
	<item>
		<title><![CDATA[CV Therapeutics Inc. Q4 2007 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-229672.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator Instructions Your first question comes from the line of Jim Birchenough. Louis Lange Hi, Jim. Jim Birchenough - Lehman Brothers Hi, guys. Just a couple of questions, one on your cash burn guidance. You are already on a cash burn run rate for less $85 million...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 27 Feb 2008 12:23:07 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/cv+therapeutics+inc..html"><![CDATA[CV Therapeutics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CVTX</category>
		<category domain="tickers">CVTX</category>
	</item>
	<item>
		<title><![CDATA[CV Therapeutics Q3 2007 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-232001.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator Instructions. Your first question comes from the line of Mark Monane, with Needham. Mark Monane - Needham Thank you very much for taking my question, and for the thorough review of the busy quarter. Lou Lange Hi, Mark. Mark Monane - Needham A couple of questions....]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 06 Nov 2007 17:30:20 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/cv+therapeutics+inc..html"><![CDATA[CV Therapeutics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CVTX</category>
		<category domain="tickers">CVTX</category>
	</item>
</channel>
</rss>
